North America Western Blotting Market Trends, Size, Segment and Growth by Forecast to 2030
North America Western Blotting Market Outlook (2019-2027)
The North
American western blotting market is projected to grow from US$ 257.05
million in 2018 to US$ 404.96 million by 2027, at a CAGR of 5.4%
during the forecast period (2019-2027).
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐
๐๐๐
๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ -
https://www.businessmarketinsights.com/sample/TIPRE00006462
Key Growth Drivers:
- Rising
Investments in Proteomic Research – Increased funding and advancements
in protein analysis continue to fuel market expansion.
- Growing
Prevalence of Lyme Disease & HIV – Western blot plays a crucial
role in confirming diagnoses for these conditions.
However, the adoption of alternative protein detection
technologies may slow market growth in the coming years.
Western Blotting & Lyme Disease Prevalence
Western blotting remains a gold standard for confirmatory
testing in diagnostics and research. Lyme disease, a tick-borne illness, is a
growing concern in North America. A 2018 study by Carnegie Mellon University
indicated that climate change is driving an increase in Lyme disease cases
across the United States. Research also suggests that western blot IgM
testing offers 94-96% specificity for patients displaying clinical symptoms
of Lyme disease.
As research investments rise and disease prevalence
increases, the western blotting market is expected to experience steady growth.
The prevalence of HIV/AIDS has increased during recent years
worldwide. Acquired immunodeficiency syndrome (AIDS) is a chronic, possibly
life-threatening condition that is caused by a human immunodeficiency virus
(HIV). The virus is responsible for damaging the immune system, where HIV
interferes with the body's ability to fight the organisms that cause disease.
As per the data provided by the US Department of Health & Human Services
and supported and the Secretary’s Minority AIDS Initiative Fund (SMAIF), in
2017, approx. 36.9 million people were living worldwide with HIV/AIDS. A
massive majority of people living with HIV are in low- and middle-income
countries. For instance, according to the India HIV Estimation 2017 report
(National Informatics Centre), in India, the prevalence of HIV is estimated at
0.22% (0.16%–0.30%). Moreover, an adult HIV prevalence is estimated at 0.25%
(0.18%-0.34%) among males and at 0.19% (0.14-0.25) among Females. Western blot
is used in the confirmatory test for HIV followed by ELISA test. Western blot
was the specifically gold standard for the diagnosis of HIV-1 infection.
According to data published on the site of HIV.gov in 2016, approximately
38,700 people were newly infected by HIV. Therefore, the above-mentioned
factors help to upsurge the market in the coming years.
North America Western Blotting Strategic Insights
Strategic insights for the North America Western Blotting
provides data-driven analysis of the industry landscape, including current
trends, key players, and regional nuances. These insights offer actionable
recommendations, enabling readers to differentiate themselves from competitors
by identifying untapped segments or developing unique value propositions.
Leveraging data analytics, these insights help industry players anticipate the
market shifts, whether investors, manufacturers, or other stakeholders. A
future-oriented perspective is essential, helping stakeholders anticipate
market shifts and position themselves for long-term success in this dynamic
region. Ultimately, effective strategic insights empower readers to make
informed decisions that drive profitability and achieve their business
objectives within the market.
North America Western Blotting Report Scope
Report Attribute |
Details |
Market size in 2018 |
US$ 257.05 Million |
Market Size by 2027 |
US$ 404.96 Million |
Global CAGR (2019 - 2027) |
5.4% |
Historical Data |
2016-2017 |
Forecast period |
2019-2027 |
Segments Covered |
By Product: Instruments, Consumables |
By Application: Biomedical & Biochemical
Research, Agriculture |
By End User: Biotechnological and Pharmaceutical
Companies, Diagnostic Laboratories, Academic and Research Institutes |
Regions and Countries Covered |
North America: US, Canada, Mexico |
Market leaders and key company profiles |
Thermo Fisher Scientific Inc., Merck KGaA, GENERAL
ELECTRIC, Cell Signaling Technology, Inc., PerkinElmer, Inc., Bio-Rad
Laboratories, Inc., LI-COR, Inc., OriGene Technologies, Inc., Rockland
Immunochemicals Inc., Abcam plc |
North America Western Blotting Regional Insights
The geographic scope of the North America Western Blotting
refers to the specific areas in which a business operates and competes.
Understanding local distinctions, such as diverse consumer preferences (e.g.,
demand for specific plug types or battery backup durations), varying economic
conditions, and regulatory environments, is crucial for tailoring strategies to
specific markets. Businesses can expand their reach by identifying underserved
areas or adapting their offerings to meet local demands. A clear market focus
allows for more effective resource allocation, targeted marketing campaigns,
and better positioning against local competitors, ultimately driving growth in
those targeted areas.
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment